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http:WHAT THIS PAPER ADDS
Urgent carotid intervention is indicated for stroke resulting from signiﬁcant carotid stenosis, but performing such
intervention soon after thrombolysis may be associated with increased risk of bleeding and other complications.
By analysing the 30-day stroke or death rates in published series of patients who have undergone carotid
intervention within 14 days of thrombolysis, this systematic review concludes that early carotid endarterectomy
post-thrombolysis appears to be safe, with stroke or death rates similar to that of surgery without thrombolysis.Objectives: Thrombolysis is effective in improving clinical outcome in the treatment of acute ischaemic stroke.
However, thrombolysis results in low recanalisation rates, particularly in the event of carotid occlusion. Carotid
intervention is indicated in stroke resulting from signiﬁcant carotid atherosclerosis, but intervention soon after
thrombolysis may be associated with increased risks. This study aims to assess the safety of carotid intervention
post-thrombolysis for acute ischaemic stroke.
Design: Systematic review.
Materials and methods: MEDLINE and EMBASE were searched on 29 May 2014. Inclusion criteria were (i) intra-
arterial or intravenous thrombolysis for acute ischaemic stroke; (ii) carotid intervention within 14 days of
thrombolysis; and (iii) derivable primary outcome. The primary outcome was 30-day stroke or death. A meta-
analysis of incidence was completed for the 30-day stroke or death rates using FreemaneTukey arcsine
transformations and assuming random effects. Point estimates with conﬁdence intervals (CIs) were generated
and heterogeneity was assessed. The strength of recommendations and quality of underlying evidence were
assessed using the American College of Chest Physicians (ACCP) grading system.
Results: Nine included publications recorded 114 carotid endarterectomy (CEA) and four angioplasty
interventions. The point estimate of 30-day stroke or death for CEA was 4.93% (95% CI 1.83e9.44), representing
four of 114. The strength of recommendation and quality of underlying evidence for CEA as per the ACCP grading
system was determined as 1C. There were no cases of stroke or death in patients undergoing angioplasty post-
thrombolysis (0/4).
Conclusions: Early CEA post-thrombolysis appears safe, with stroke or death rates similar to that of the operation
without thrombolysis. However, the wide CI obtained highlights the uncertainty of this result. Further, we
emphasise that this recommendation is supported by low-quality evidence. Additional data are required to
conﬁrm the safety of surgery and early endovascular therapy post-thrombolysis.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 8 April 2014, Accepted 6 August 2014, Available online 10 September 2014
Keywords: Angioplasty, Carotid arteries, Endarterectomy, Safety, Stroke, ThrombolysisINTRODUCTION
Acute ischaemic stroke is a leading cause of death and
disability worldwide.1 According to the World Strokeof original article: http://dx.doi.org/10.1016/j.ejvs.2014.08.018
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//dx.doi.org/10.1016/j.ejvs.2014.08.012Organization, one in six people will have a stroke in their
lifetime, with a mortality rate of 25% in the ﬁrst year.2,3
Thrombolysis has revolutionised ischaemic stoke therapy
with the potential to acutely reverse symptomatology and
permit complete recovery.2 The most well-studied drugs for
thrombolysis, including streptokinase, urokinase, and re-
combinant tissue plasminogen activator, work by converting
plasminogen to plasmin to break down ﬁbrin in blood
clots.2
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dard therapy in acute ischaemic stroke,4 partial or complete
recanalisation following thrombolysis only occurs in
approximately 10% of occluded internal carotid arteries and
in 25% of occluded proximal middle cerebral arteries.5,6
Further, more than 80% of stroke patients with a National
Institutes of Health Stroke Scale score of 10 have persis-
tent arterial occlusion despite thrombolysis.7 In such cir-
cumstances, and/or in the presence of signiﬁcant carotid
stenosis, it is important to consider early operative
intervention.
Carotid intervention, including carotid endarterectomy
(CEA) and angioplasty, is indicated in symptomatic carotid
stenosis of 50e99%, according to the North American
Symptomatic Carotid Endarterectomy Trial (NASCET)
criteria,8 or 70e99%, according to the European Carotid
Surgery Trialists’ (ECST)9 Collaborative Group criteria, within
2 weeks of onset of stroke or transient ischaemic attack
symptoms.10 With the risk of recurrent ischaemic attack
being highest within the days following the ﬁrst episode,11
there has been a recent move towards performing carotid
intervention as soon as possible after the onset of symp-
toms.12e14 Recent evidence suggests no additional proce-
dural risk if the intervention is performed in the hyperacute
period, whether this time period is deﬁned as <48 h, <7
days, or <14 days.13
However, thrombolysis up to 6 h after the onset of stroke
has been found to increase the risk of symptomatic and
fatal intracranial haemorrhage approximately fourfold
within the ﬁrst 7 days, even after the clearance of throm-
bolysis.15 Data from a recent meta-analysis have identiﬁed
an incidence of symptomatic intracranial haemorrhage of
7.7% in patients treated with alteplase alone within 6 h for
acute ischaemic stroke.15 Therefore, while early carotid
intervention is indicated in stroke resulting from carotid
stenosis, performing carotid intervention soon after
thrombolysis may be associated with an increased risk of
bleeding and other complications.
This systematic review aims to assess the safety of carotid
intervention post-thrombolysis by analysing the 30-day
stroke or death rates in published series of patients who
have undergone carotid intervention post-thrombolysis.
MATERIALS AND METHODS
Search strategy
A systematic review adhering to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses was per-
formed.16 MEDLINE and EMBASE were searched using the
Ovid portal. The databases were searched on 29 May 2014,
for articles published between 1947 and 2014. The search
string used was: [stroke and thrombolysis and carotid and
endarterectomy] or [stroke and thrombolysis and carotid
and (stent or angioplasty or intervention or
thrombectomy)].
Two authors (R.M. and M.I.Q.) searched independently
and compared results at each stage. A third author (A.H.D)
arbitrated disagreements. Authors of cases presented inconference proceedings were contacted where further de-
tails were required. Data abstraction and quality assess-
ment were conducted by two independent investigators
(R.M. and M.I.Q.).
Inclusion and exclusion criteria
Studies were considered for summation analysis according
to the following inclusion criteria: intra-arterial or intrave-
nous thrombolysis for acute ischaemic stroke; carotid
intervention within 14 days of thrombolysis; derivable pri-
mary outcome; intervention conducted on internal carotid
artery; and internal carotid stenosis conﬁrmed on imaging.
Studies were excluded based on the following exclusion
criteria: case series with fewer than ﬁve cases; review ar-
ticles; non English-language studies; intraoperative throm-
bolysis; and intervention conducted on middle cerebral
artery.
Primary and secondary outcomes
The primary outcome measure was 30-day stroke or death.
Secondary outcome measures included bleeding complica-
tions; cranial nerve injury; and wound complications
(deﬁned as delayed healing or infection, or wound hae-
matoma at site of surgery).
Analysis
The quality of studies was assessed in domains of study
design; study duration; sample size; inclusion and exclusion
criteria; diagnosis and follow-up by stroke neurologist;
operative technical details; postoperative control of blood
pressure; and source of funding. The strength of recom-
mendations and quality of underlying evidence were
assessed using the American College of Chest Physicians
(ACCP) grading system, which is a modiﬁed approach to the
international GRADE group.17 The grading scheme classiﬁes
recommendations as strong (grade 1) or weak (grade 2),
according to the balance between beneﬁts, risks, burdens,
and the degree of conﬁdence in estimates of beneﬁts, risks,
and burdens. The system classiﬁes the quality of evidence as
high (grade A), moderate (grade B), or low (grade C) ac-
cording to factors that include study design, consistency of
the results, and directness of evidence.
A meta-analysis of incidence was completed for the 30-
day stroke or death rates using FreemaneTukey arcsine
transformations and assuming random effects as described
by DerSimonian and Laird.18 Point estimates with conﬁ-
dence intervals (CIs) were generated and heterogeneity was
assessed. I2 is reported, which is a measure of the degree of
inconsistency in study results. I2 describes the percentage of
total variation across studies that is due to heterogeneity
rather than chance with values ranging from 0 to 100%. The
I2 value is proportional to the heterogeneity across studies,
with a value of 0% representing no heterogeneity and larger
values demonstrating increasing heterogeneity. I2 is re-
ported with 95% uncertainty intervals. Calculations were
performed using MedCalc for Windows, version 13.1.2.0
(MedCalc Software, Mariakerke, Belgium).
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After duplicates were removed, 588 articles were screened,
of which nine studies (eight full-text articles and one con-
ference abstract) were included for summation analysis
(Fig. 1).
The characteristics of the included studies are displayed
in Table 1, including reported 30-day stroke or death data.
The quality assessment of included studies can be seen in
Table 2. All included studies were performed retrospectively
with a mean sample size of 13 patients (range 5e52; SD
14.6).Primary outcome
The point estimate of 30-day stroke or death for CEA using a
random effects meta-analysis model was 4.93% (95% CI
1.83e9.44). This represents four cases in 114. The I2 was
0.00% (95% CI 0.00e34.95).
In one of these cases, a 49-year-old woman who was
administered intravenous thrombolysis for an initial com-
bined intracranial internal carotid artery (ICA)emiddle ce-
rebral artery occlusion was operated upon 33 h after strokeRecords identified through MEDLINE 
and EMBASE searching
(n = 709)
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Figure 1. Preferred Reporting Items for Systematic Ronset for residual ICA stenosis. She developed a haemor-
rhagicl stroke 24 h postoperatively.
The second case involved a 66-year-old woman who
underwent a CEA within 12 days of intravenous thrombol-
ysis. She suffered a postoperative intracranial haemorrhage
on the same day following CEA.
The third and fourth cases involved two 81-year-old men
treated with CEA within 5 days of thrombolysis and who
suffered a retinal infarction and minor hemispheric stroke,
respectively, post-CEA.
There were four included cases of angioplasty (without
stenting) post-thrombolysis, in which there was no stroke or
death. No studies reported stroke or death in patients un-
dergoing angioplasty (without stenting) post-thrombolysis.Secondary outcome
Only one of nine included studies reported on cranial nerve
injury, in which no patient experienced cranial nerve injury.
Bleeding complications were documented in two studies
investigating CEA post-thrombolysis, with two out of 27
patients experiencing bleeding (7%). Wound complicationsplicates removed
588)
ened (title and 
(n = 588)
les assessed 
gibility
132)
Full-text articles excluded, with 
reasons
(n = 123)
Reasons for exclusion:
no primary outcomes obtained (n
= 93)
insufficient case number (n = 10)
patients undergoing thrombolysis 
not specified (n = 5)
carotid intervention not within 14 
days of thrombolysis (n = 2)
no thrombolysis preceding carotid 
intervention (n = 7) 
nonEnglish-language study (n = 
6)
included in 
e synthesis
= 9)
Additional records identified through 
other sources
(n = 8)
eviews and Meta-analyses (PRISMA) diagram.16
Table 1. Characteristics of included studies.
Study Country Study
design
Patients
meeting
inclusion
criteria (n)
Age (years)
mean/median
(range)
Male:
female
ratio
IAT/IVT Intervention:
CEA/angioplasty
Onset-to-IVT/
IAT (h)
Thrombolysis to
intervention time
(mean/median)
(range)
Onset to
intervention
time (mean/
median)
(range)
30-day
stroke
(n)
30-day
death
(n)
30-day
stroke
or death
(n)
Rathenborg
et al., 201311
Denmark R 22 71 (66e77) 18:4 IVT CEA 4.5 NR 11 d (7e13) 0 0 0
Leseche
et al., 201214
France R 7 NR NR IVT CEA 3.0 NR <14 d 0 0 0
Bartoli
et al., 200932
France R 9 60 (49e79) 7:2 IVT CEA 3.0 Within 12 d 12 d 1 0 1
McPherson
et al., 200133
America R 5 59 (75e72) 4:1 All patients
had IVT, 3
patients
also had IAT
CEA NR <48 h Mean ¼ 24.6 h 0 0 0
Endo et al.,
199834
Japan R 5 64 (49e76) 5:0 IAT Angioplasty
(n ¼ 4); CEA
(n ¼ 1)
6.0 CEA performed 8 h
later. Angioplasty
all performed
immediately
NR 0 0 0
Shalhoub
et al., 201135
England R 6 69 (51e75) 4:2 IVT CEA NR 5.5 d (4e9) NR 0 0 0
Yong et al.,
201325
England R 7 71 (62e84) 5:2 IVT CEA 4.5 NR 7 d (2e12) 1 0 1
Koraen-Smith
et al., 201436
Sweden R 52 NR NR IVT CEA 6.0 <14 d NR 2 0 2
Benes et al.
201437
Czech Republic R 5 63 (54e68) 1:4 IVT CEA 4.5 <5 h <6 h 0 0 0
Note. R ¼ retrospective; NR ¼ not reported; IAT ¼ intra-arterial thrombolysis; IVT ¼ intravenous thrombolysis; CEA ¼ carotid endarterectomy.
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Table 2. Quality assessment.
Study Study
design
Study
duration
(y)
Patients
(n)
Inclusion criteria Exclusion criteria Diagnosis
by stroke
neurologist
Operation
technical
details given
Measures taken to
prevent high blood
pressure in the
postoperative period
Follow-up
examination
performed by
neurologist
Source of
funding
Rathenborg
et al., 201311
R 5 22 IVT before CEA
for stroke
NR NR No Yes No Nil
Leseche
et al., 201214
R 8 7 All patients with stroke
in evolution and ipsilateral
high-grade ICA stenosis
and who underwent
operation  2 weeks of
index event
NR NR Yes Yes Yes Nil
Bartoli
et al., 200932
R NR 9 IVT before CEA for stroke Persistent severe
neurological deﬁcit;
previous radical neck
dissection; cervical
irradiation; expectation
of poor surgical risk
Yes No Yes Yes Nil
McPherson
et al., 200133
R 3 5 Patients who met all the
inclusion criteria and
none of the exclusion
criteria for thrombolysis
NR Yes No NR NR NR
Endo et al.,
199834
R 6 5 Acute ICA occlusion,
treated with thrombolysis
within 6 h
Age > 80 y; deep
coma; gradually
improving symptoms;
critical condition;
known contraindication
to ﬁbrinolysis;
inability to obtain
informed consent
NR Yes Yes NR NR
Shalhoub
et al., 201135
R 2 6 CEA within 2 weeks of
thrombolysis
NR NR No NR NR NR
Yong et al.,
201325
R 3 7 Patients operated within
30 days of stroke onset
NR NR No Yes NR Nil
Koraen-Smith
et al.,36
R 4 52 Patients with carotid
intervention post-stroke
NR Yes Yes NR Yes Declared
Benes et al.,
201437
R 3 5 Patients with ischaemic
stroke with NIHSS > 5
and ICA occlusion.
NR Yes Yes NR Yes NR
Note. R ¼ retrospective; NR ¼ not reported; IVT ¼ intravenous thrombolysis; CEA ¼ carotid endarterectomy; ICA ¼ internal carotid artery; NIHSS ¼ National Institutes of Health Stroke Scale.
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510 R. Mandavia et al.were recorded in one study investigating CEA; no wound
complications were observed.
The strength of recommendation and quality of under-
lying evidence as per the ACCP grading system was deter-
mined as 1C.17 This represents a strong recommendation
with low-quality or very low-quality evidence, and a
recommendation that may change if/when higher quality
evidence becomes available. This grade was established
owing to (i) existing evidence clearly suggesting that early
CEA within 14 days of thrombolysis is safe; and (ii) sup-
porting evidence being observational studies or case series.
DISCUSSION
The aim of this systematic review was to assess the safety of
early carotid intervention post-thrombolysis. All patients
had conﬁrmed signiﬁcant ICA stenosis, underwent carotid
intervention within 14 days of thrombolysis, and had 30-day
stroke or death outcomes recorded. Two types of carotid
intervention were included for analysis: CEA and angio-
plasty (without stenting).CEA
In a pooled analysis of the NASCET and ECST trials, patients
who underwent CEA had a 7.0% stroke or death rate at 30
days.19 Furthermore, two large trialsdEVA-3S (‘Endarter-
ectomy versus stenting in patients with symptomatic severe
carotid stenosis’)20 and SPACE (‘Stent-supported Percuta-
neous Angioplasty of the Carotid Artery versus Endarter-
ectomy’)21dreported 30-day stroke or death rates of 3.9%
and 6.3%, respectively, post-CEA for symptomatic ICA ste-
nosis. Similar rates were obtained by the Carotid and
Vertebral Artery Transluminal Angioplasty Study (CAVATAS;
5.9%),22 the Carotid Revascularization Endarterectomy
Versus Stenting Trial (3.2%),23 and the International Carotid
Stenting Study (3.4%).24
In this systematic review, the point estimate of 30-day
stroke or death for CEA was 4.93% (95% CI 1.83e9.44),
representing four cases in 114. While this may suggest that
early CEA (14 days) appears safe, with stroke or death
rates similar to that of the operation without thrombolysis,
the wide CI highlights the uncertainty of this result. The I2
was 0.00% (95% CI 0e34.95), indicating a low level of
heterogeneity between studies concerning rates of stroke
or death in patient with CEA.
Further, as highlighted by the ACCP grading system,17 this
recommendation is supported by low-quality or very low-
quality evidence, meaning that such a recommendation
may change if/when higher quality evidence becomes
available.
These ﬁndings are supported by a 2013 systematic review
by Yong et al.,25 which reported a pooled 30-day stroke or
death rate for CEA following thrombolysis for acute
ischaemic stroke of 3.0% (2/77). However, it should be
noted that this study included patients who underwent CEA
within 30 days of stroke onset, thereby not assessing the
safety of CEA in the acute period during which intervention
is recommended for symptomatic disease (14 days).10Further, this review had no minimum sample size inclu-
sion criteria and was limited to studies published up to
August 2012.
Angioplasty
The potential beneﬁt of angioplasty as an alternative to CEA
was highlighted by CAVATAS.22 Since the completion of
CAVATAS, angioplasty with stenting has largely replaced
angioplasty alone, with studies reporting fewer complica-
tions and improved outcomes.22 Despite the increasing
utility of carotid stenting,24,26,27 no studies investigating the
safety of such intervention post-thrombolysis were identi-
ﬁed that met simple inclusion criteria.
Angioplasty soon after thrombolysis has been found to
be safe in the management of acute myocardial infarc-
tion.28e30 In the Rescue Angioplasty versus Conservative
Treatment or Repeat Thrombolysis (REACT) trial, Gershlick
et al.31 highlighted the safety and efﬁcacy of coronary an-
gioplasty post-thrombolysis. In a randomised multicentre
trial, Bonnefoy et al. obtained similar ﬁndings.29
In the present study, as no patients undergoing angio-
plasty (without stenting) suffered stroke or death in the
small series published, the safety of this procedure post-
thrombolysis could not be estimated.
The secondary outcomes obtained are difﬁcult to inter-
pret owing to the paucity of recorded surgical complica-
tions. It appears that there is a relatively low risk of
bleeding and wound complications, but, again, prospective
data from large cohorts or patients are required.
Despite the impetus to surgically treat signiﬁcant carotid
atherosclerosis as early as possible following cerebral insult,
signiﬁcant heterogeneity in reported intervention timings
prohibited detailed analysis of safety if the intervention was
performed in the hyperacute period (48 h) following
thrombolysis.
Limitations
First, the included studies consisted of observational studies
or case series with small sample sizes. The formal quality
assessment implemented highlights the low-quality evi-
dence available. Second, data concerning cranial nerve
injury, and bleeding and wound complications were only
partially available, limiting the ability to draw conclusions
on the secondary outcomes. Finally, the presence of
reporting bias must also be considered and, to address
these limitations, prospective registry data are required to
generate the required numbers to assess accurately the
safety of carotid revascularization post-thrombolysis.
CONCLUSIONS
In situations of acute ischaemic stroke, where patients have
residual carotid artery stenosis post-thrombolysis, early CEA
(14 days) appears safe with stroke or death rates similar
to that of the operation without thrombolysis. However, the
wide CI obtained highlights the uncertainty of this result,
which is supported by low-quality evidence. With no cases
of stroke or death concerning angioplasty, the safety of this
Safety of carotid intervention following thrombolysis 511intervention post-thrombolysis could not be estimated.
Prospective registry data are required to verify these ﬁnd-
ings and accurately determine the optimal timing of carotid
intervention post-thrombolysis.CONFLICT OF INTEREST
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